Correlation Between Precision BioSciences and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and Kymera Therapeutics, you can compare the effects of market volatilities on Precision BioSciences and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and Kymera Therapeutics.
Diversification Opportunities for Precision BioSciences and Kymera Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Precision and Kymera is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Precision BioSciences and Kymera Therapeutics
Given the investment horizon of 90 days Precision BioSciences is expected to generate 2.32 times more return on investment than Kymera Therapeutics. However, Precision BioSciences is 2.32 times more volatile than Kymera Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.06 per unit of risk. If you would invest 460.00 in Precision BioSciences on October 20, 2024 and sell it today you would earn a total of 36.00 from holding Precision BioSciences or generate 7.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Precision BioSciences vs. Kymera Therapeutics
Performance |
| Timeline |
| Precision BioSciences |
| Kymera Therapeutics |
Precision BioSciences and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Precision BioSciences and Kymera Therapeutics
The main advantage of trading using opposite Precision BioSciences and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Precision BioSciences vs. X4 Pharmaceuticals | Precision BioSciences vs. Acumen Pharmaceuticals | Precision BioSciences vs. Inozyme Pharma | Precision BioSciences vs. Terns Pharmaceuticals |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |